{
  "id": 778568,
  "title": "Karyopharm has a month left to salvage its cancer expansion plans",
  "url": "https://urgent.news/2026/08/13/karyopharm-has-a-month-left-to-salvage-its-cancer-expansion-plans",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-13T14:43:15.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/karyopharm-has-a-month-left-to-salvage-its-cancer-expansion-plans/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A commercial-stage cancer drugmaker with a market cap about one-third the size of its projected 2026 revenues is on the brink of defaulting. Karyopharm Therapeutics said Thursday that it has until ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}